Singapore CT Scan Market Analysis

Singapore CT Scan Market Analysis


$ 3999

Singapore CT Scan Market was valued at $5.53 Mn in 2023 and is predicted to grow at a CAGR of 8.47% from 2023 to 2030, to $9.77 Mn by 2030. The key drivers of this industry include rising affluence and healthcare expenditure, the growing burden of chronic diseases, and the aging population. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.

ID: IN10SGMD022 CATEGORY: Medical Devices GEOGRAPHY: Singapore AUTHOR: Sarita Yadav

Buy Now

Singapore CT Scan Market Executive Summary

Singapore CT Scan Market was valued at $5.53 Mn in 2023 and is predicted to grow at a CAGR of 8.47%from 2023 to 2030, to $9.77 Mn by 2030.

A CT scan, or computed tomography scan, is a sophisticated imaging procedure that uses X-rays to produce detailed cross-sectional images of the body. Unlike traditional X-rays, CT scans capture multiple views from various angles, which a computer then processes into a three-dimensional representation of internal structures such as organs, bones, and soft tissues. Before the scan, patients may prepare by wearing a gown and removing metal objects. Depending on the type of scan, they might need to ingest a contrast material to enhance the visibility of specific tissues. During the scan, patients lie on a table that moves through a donut-shaped scanner while X-ray images are taken. Afterward, a radiologist interprets the images to diagnose conditions like cancer, heart disease, bone fractures, internal bleeding, and injuries. While CT scans offer detailed diagnostic capabilities, they involve radiation exposure and can be costly, though advancements have minimized risks and enhanced safety. Other imaging options like X-rays, ultrasound, and MRI scans are considered based on specific medical needs and radiation concerns.

Chronic diseases, which account for over 74% of global deaths annually according to the World Health Organization (WHO), are primarily managed through ongoing medical interventions. In Singapore, a significant portion of the population aged 18-74 years is affected by chronic health conditions. Hypertension, or high blood pressure, affects 37% of this demographic, while diabetes affects 9.5%. Hyperlipidemia, characterized by high cholesterol levels, impacts 31.9% of individuals in this age group. Additionally, chronic kidney disease has a prevalence rate of 15.6% among the Singaporean population.

The market is therefore driven by significant factors like rising affluence and healthcare expenditure, the growing burden of chronic diseases, and the aging population. However, high costs, skilled workforce, and radiation concerns restrict the growth and potential of the market.

A prominent player in this field is GE Healthcare, which launched a new refurbishing unit in Bangladesh for A1-Sure Ultrasound Systems, aiming to enhance accessibility to affordable ultrasound technology in developing regions, and Siemens Healthineers partnered with Microsoft to utilize Azure cloud services for AI-powered medical imaging solutions, aimed at advancing healthcare delivery with secure and scalable cloud computing. Other contributors include Canon Medical Systems, and NeuroLogica Corp. among others.

Singapore CT Scan Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Rising Affluence and Healthcare Expenditure: Singapore boasts a high GDP per capita of $72,838 in 2023 according to the World Bank and prioritizes healthcare. This translates to increased spending on advanced medical technologies like CT scanners, driving market growth.

Growing Burden of Chronic Diseases: Chronic diseases like cancer are a concern. The Singapore Cancer Registry reported over 43,000 new cancer cases in 2020. CT scans play a vital role in early detection, treatment planning, and monitoring, propelling market demand.

Aging Population: Singapore's population is aging. As of 2023, over 16% are aged 65 or above according to the Department of Statistics, Singapore. This demographic shift increases the need for advanced diagnostics like CT scans for accurate diagnoses and treatment planning.

Market Restraints

High Costs: CT scans can be expensive, with the cost varying depending on the type of scan, contrast material used, and facility fees. The cost can be a barrier for some patients, particularly those without adequate health insurance.

Skilled Workforce: Operating and interpreting CT scans requires specialized training. While Singapore has a well-developed healthcare system, ensuring a sufficient number of qualified radiologists and technicians across all healthcare facilities might be a challenge.

Radiation Concerns: Despite its benefits, radiation exposure from CT scans is a concern. This might lead some patients to opt for alternative imaging methods, when possible, potentially slowing market growth for specific applications.

Regulatory Landscape and Reimbursement Scenario

Singapore's Health Sciences Authority (HSA) strictly regulates the CT scan market. The HSA enforces rigorous standards for safety, efficacy, and quality control of CT scanners. Manufacturers must obtain approval from the HSA before marketing or selling their CT scanners in Singapore. This process ensures a high level of quality in the market but can be time-consuming for manufacturers.

Reimbursement for CT scans in Singapore is a multi-layered system. The government-funded MediShield Life plan offers basic coverage for medically necessary CT scans for Singaporean citizens and permanent residents. However, specific coverage details depend on the type of scan, the medical condition being diagnosed, and the specific MediShield Life plan a patient holds. Private insurance plans can offer additional coverage, but navigating the entire reimbursement landscape can be complex for both patients and healthcare providers. There can also be out-of-pocket expenses for patients depending on their insurance coverage.

Competitive Landscape

Key Players

Here are some of the major key players in the Singapore CT Scan Market:

  • GE HealthCare
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Canon Medical Systems
  • NeuroLogica Corp.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Fujifilm Holdings Corporation
  • Shenzhen Anke High-tech Co., Ltd.
  • Koning Health
  • Carestream Dental LLC.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Singapore CT Scan Market Segmentation

By Technology

  • High-end Slice CT
  • Mid-end Slice CT
  • Low-end Slice CT
  • Cone Beam CT (CBCT)

By Application

  • Oncology
  • Cardiology
  • Vascular
  • Neurology
  • Musculoskeletal
  • Others

By Modality

  • O-Arms
  • C- Arms

By End-User

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 23 July 2024
Updated by: Anish Swaminathan

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up